Prevention of menstrual migraine with perimenstrual transdermal 17-ß-estradiol: a randomized, placebo-controlled, double-blind crossover study  

Oleh:

Almen-Christensson, Anna ; Hamma, Mats ; Lindh-Astrand, Lotta ; Landtblom, Anne-Marie ; Brynhildsen, Jan

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: Fertility and Sterility (keterangan: ada di ClinicalKey) vol. 96 no. 02 (Aug. 2011), page 498-500.
Topik: Menstrual migraine; estradiol; RCT

Ketersediaan

Perpustakaan FK Nomor Panggil: F02.K.2011.04 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

The effect of treatment with percutaneous E2 (100 µg/24 h) during 2 weeks perimenstrually on the number and severity of menstrual migraine attacks was studied in 27 women in a randomized, placebo-controlled, double-blind, crossover trial. We were not able to demonstrate any difference between E2 supplementation and placebo on the number or severity of migraine attacks, but both regimens showed significant effects compared with before treatment.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali